Patents by Inventor Kevin Gene Peters

Kevin Gene Peters has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereof
    Patent number: 11814425
    Abstract: Antibodies and antigen binding fragments thereof that bind to human protein tyrosine phosphatase beta (HPTP?), and uses thereof.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: November 14, 2023
    Assignee: Eye Point Pharmaceuticals, Inc.
    Inventors: Rocco Jamie Rotello, Kevin Gene Peters, Michael Glenn Davis
  • COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES
    Publication number: 20220016086
    Abstract: Disclosed are methods for the treatment of diseases or conditions of the eye, especially retinopathies, ocular edema and ocular neovascularization. Non-limiting examples of these diseases or conditions include diabetic macular edema, age-related macular degeneration (wet form), choroidal neovascularization, diabetic retinopathy, retinal vein occlusion (central or branch), ocular trauma, surgery induced edema, surgery induced neovascularization, cystoid macular edema, ocular ischemia, uveitis, and the like.
    Type: Application
    Filed: June 21, 2021
    Publication date: January 20, 2022
    Inventors: Kevin Gene PETERS, Robert Shalwitz
  • Methods of treating intraocular pressure with activators of Tie-2
    Patent number: 10952992
    Abstract: Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for eye conditions associated with angiogenesis, for example, intraocular pressure, ocular hypertension, and glaucoma.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: March 23, 2021
    Assignee: AERPIO PHARMACEUTICALS, INC.
    Inventor: Kevin Gene Peters
  • ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF
    Publication number: 20200407430
    Abstract: Antibodies and antigen binding fragments thereof that bind to human protein tyrosine phosphatase beta (HPTP?), and uses thereof.
    Type: Application
    Filed: February 7, 2020
    Publication date: December 31, 2020
    Inventors: Rocco Jamie Rotello, Kevin Gene Peters, Michael Glenn Davis
  • METHODS FOR TREATING VASCULAR LEAK SYNDROME
    Publication number: 20200277267
    Abstract: Disclosed are methods for treating Vascular Leak Syndrome. Further disclosed are methods for treating vascular leakage due to inflammatory diseases, inter alia, sepsis, lupus, irritable bowel disease. Yet further disclosed are methods for treating renal cell carcinoma and melanoma. Still further disclosed are methods for reducing metastasis of malignant cells and/or preventing the proliferation of carcinoma cells via spreading due to vascular leakage.
    Type: Application
    Filed: May 13, 2020
    Publication date: September 3, 2020
    Inventors: Robert Shalwitz, Kevin Gene Peters
  • METHODS FOR TREATING VASCULAR LEAK SYNDROME
    Publication number: 20200207730
    Abstract: Disclosed are methods for treating Vascular Leak Syndrome. Further disclosed are methods for treating vascular leakage due to inflammatory diseases, inter alia, sepsis, lupus, irritable bowel disease. Yet further disclosed are methods for treating renal cell carcinoma and melanoma. Still further disclosed are methods for reducing metastasis of malignant cells and/or preventing the proliferation of carcinoma cells via spreading due to vascular leakage.
    Type: Application
    Filed: December 18, 2019
    Publication date: July 2, 2020
    Inventors: Robert Shalwitz, Kevin Gene Peters
  • COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES
    Publication number: 20200009115
    Abstract: Disclosed are methods for the treatment of diseases or conditions of the eye, especially retinopathies, ocular edema and ocular neovascularization. Non-limiting examples of these diseases or conditions include diabetic macular edema, age-related macular degeneration (wet form), choroidal neovascularization, diabetic retinopathy, retinal vein occlusion (central or branch), ocular trauma, surgery induced edema, surgery induced neovascularization, cystoid macular edema, ocular ischemia, uveitis, and the like.
    Type: Application
    Filed: July 16, 2019
    Publication date: January 9, 2020
    Inventors: Kevin Gene PETERS, Robert Shalwitz
  • COMPOUNDS, COMPOSITIONS, AND METHODS FOR PREVENTING METASASIS OF CANCER CELLS
    Publication number: 20190076405
    Abstract: Disclosed are methods for preventing metastasis of cancer cells. The disclosed compounds can be used to prevent the spread of tumor or other types of cancer cells.
    Type: Application
    Filed: March 6, 2018
    Publication date: March 14, 2019
    Inventors: Robert Shalwitz, Kevin Gene Peters
  • ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF
    Publication number: 20190023773
    Abstract: Antibodies and antigen binding fragments thereof that bind to human protein tyrosine phosphatase beta (HPTP?), and uses thereof.
    Type: Application
    Filed: February 12, 2018
    Publication date: January 24, 2019
    Inventors: Rocco Jamie Rotello, Kevin Gene Peters, Michael Glenn Davis
  • Compounds, compositions, and methods for preventing metastasis of cancer cells
    Patent number: 9949956
    Abstract: Disclosed are methods for preventing metastasis of cancer cells. The disclosed compounds can be used to prevent the spread of tumor or other types of cancer cells.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: April 24, 2018
    Assignee: Aerpio Therapeutics, Inc.
    Inventors: Robert Shalwitz, Kevin Gene Peters
  • PHOSPHATASE INHIBITORS FOR TREATING OCULAR DISEASES
    Publication number: 20180092883
    Abstract: Disclosed are compounds and pharmaceutical compositions effective for inhibition of HPTP-?. The compounds can provide effective therapy for ocular disease, for example, ocular edema and ocular neovascularization.
    Type: Application
    Filed: October 27, 2017
    Publication date: April 5, 2018
    Inventors: Kevin Gene Peters, Robert Shalwitz
  • Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereof
    Patent number: 9926367
    Abstract: Antibodies and antigen binding fragments thereof that bind to human protein tyrosine phosphatase beta (HPTP?), and uses thereof.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: March 27, 2018
    Assignee: AERPIO THERAPEUTICS, INC.
    Inventors: Rocco Jamie Rotello, Kevin Gene Peters, Michael Glenn Davis
  • COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES
    Publication number: 20180037579
    Abstract: Disclosed are methods for the treatment of diseases or conditions of the eye, especially retinopathies, ocular edema and ocular neovascularization. Non-limiting examples of these diseases or conditions include diabetic macular edema, age-related macular degeneration (wet form), choroidal neovascularization, diabetic retinopathy, retinal vein occlusion (central or branch), ocular trauma, surgery induced edema, surgery induced neovascularization, cystoid macular edema, ocular ischemia, uveitis, and the like.
    Type: Application
    Filed: March 17, 2017
    Publication date: February 8, 2018
    Inventors: Kevin Gene Peters, Robert Shalwitz
  • METHODS FOR TREATING VASCULAR LEAK SYNDROME
    Publication number: 20180016245
    Abstract: Disclosed are methods for treating Vascular Leak Syndrome. Further disclosed are methods for treating vascular leakage due to inflammatory diseases, inter alia, sepsis, lupus, irritable bowel disease. Yet further disclosed are methods for treating renal cell carcinoma and melanoma. Still further disclosed are methods for reducing metastasis of malignant cells and/or preventing the proliferation of carcinoma cells via spreading due to vascular leakage.
    Type: Application
    Filed: February 27, 2017
    Publication date: January 18, 2018
    Inventors: Robert Shalwitz, Kevin Gene Peters
  • ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF
    Publication number: 20170349649
    Abstract: Antibodies and antigen binding fragments thereof that bind to human protein tyrosine phosphatase beta (HPTP?), and uses thereof.
    Type: Application
    Filed: February 10, 2017
    Publication date: December 7, 2017
    Inventors: Rocco Jamie Rotello, Kevin Gene Peters, Michael Glenn Davis
  • METHODS OF TREATING INTRAOCULAR PRESSURE WITH ACTIVATORS OF TIE-2
    Publication number: 20170079959
    Abstract: Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for eye conditions associated with angiogenesis, for example, intraocular pressure, ocular hypertension, and glaucoma.
    Type: Application
    Filed: September 22, 2016
    Publication date: March 23, 2017
    Inventor: Kevin Gene Peters
  • COMPOUNDS, COMPOSITIONS, AND METHODS FOR PREVENTING METASASIS OF CANCER CELLS
    Publication number: 20160008327
    Abstract: Disclosed are methods for preventing metastasis of cancer cells. The disclosed compounds can be used to prevent the spread of tumor or other types of cancer cells.
    Type: Application
    Filed: September 24, 2015
    Publication date: January 14, 2016
    Inventors: Robert Shalwitz, Kevin Gene Peters
  • Compounds, compositions, and methods for preventing metastasis of cancer cells
    Patent number: 9174950
    Abstract: Disclosed are methods for preventing metastasis of cancer cells. The disclosed compounds can be used to prevent the spread of tumor or other types of cancer cells.
    Type: Grant
    Filed: May 8, 2014
    Date of Patent: November 3, 2015
    Assignee: Aerpio Therapeutics, Inc.
    Inventors: Robert Shalwitz, Kevin Gene Peters
  • Methods for treating vascular leak syndrome
    Patent number: 9096555
    Abstract: Disclosed are methods for treating Vascular Leak Syndrome. Further disclosed are methods for treating vascular leakage due to inflammatory diseases, inter alia, sepsis, lupus, inflammatory bowel disease. Yet further disclosed are methods for treating renal cell carcinoma and melanoma. Still further disclosed are methods for reducing metastasis of malignant cells and/or preventing the proliferation of carcinoma cells via spreading due to vascular leakage.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: August 4, 2015
    Assignee: AERPIO THERAPEUTICS, INC.
    Inventors: Robert Shalwitz, Kevin Gene Peters
  • Compounds, compositions, and methods for preventing metastasis of cancer cells
    Patent number: 8883832
    Abstract: Disclosed are methods for preventing metastasis of cancer cells. The disclosed compounds can be used to prevent the spread of tumor or other types of cancer cells.
    Type: Grant
    Filed: March 3, 2013
    Date of Patent: November 11, 2014
    Assignee: Aerpio Therapeutics Inc.
    Inventors: Robert Shalwitz, Kevin Gene Peters